Results 91 to 100 of about 45,004 (157)

A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host [PDF]

, 2019
Chavez, Sthefany M., Feldman, Mario F., Huynh, Jeremy P., Kinsella, Rachel L., Mayer, Anne E., Stallings, Christina L.   +5 more
core   +1 more source

Cost-Effectiveness Analysis of Pneumococcal Vaccines in the Pediatric Population: A Systematic Review. [PDF]

Healthcare (Basel)
Vo NX, Pham HL, Bui UM, Ho HT, Bui TT.
europepmc   +1 more source

Designing ecologically optimized pneumococcal vaccines using population genomics. [PDF]

Nat Microbiol, 2020
Colijn C, Corander J, Croucher NJ.
europepmc   +1 more source

Possible Cross-Reactivity Between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death [PDF]

Vaccines (Basel), 2020
Root-Bernstein R.
europepmc   +2 more sources

Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. [PDF]

Vaccines (Basel)
Omole T, Pelayo E, Weinberg AS, Chalkias S, Endale Z, Tamms G, Sterling TM, Good L, Shekar T, Johnson M, Banniettis N, Buchwald UK, Esteves-Jaramillo A.   +12 more
europepmc   +1 more source

Conjugate vaccines [PDF]

, 2005
Finn, A, Heath, P
core   +2 more sources

Bacterium-like Particles from Corynebacterium pseudodiphtheriticum as Mucosal Adjuvant for the Development of Pneumococcal Vaccines. [PDF]

Vaccines (Basel)
Ortiz Moyano R, Raya Tonetti F, Elean M, Imamura Y, Fukuyama K, Suda Y, Melnikov V, Suvorov A, Vizoso-Pinto MG, Kitazawa H, Villena J.   +10 more
europepmc   +1 more source

The need for a pneumococcal vaccine [PDF]

Journal of Antimicrobial Chemotherapy, 1980
openaire   +3 more sources

Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018-21. [PDF]

J Antimicrob Chemother
Schellenberg JJ, Adam HJ, Baxter MR, Karlowsky JA, Golden AR, Martin I, Zhanel GG.   +6 more
europepmc   +1 more source

Limited protection of pneumococcal vaccines against emergent Streptococcus pneumoniae serotype 14/ST876 strains. [PDF]

Infection
Lan Y, Liu L, Hu D, Ge L, Xiang X, Peng M, Fu Y, Wang Y, Li S, Chen Y, Jiang Y, Tu Y, Vidal JE, Yu Y, Chen Z, Wu X.   +15 more
europepmc   +1 more source